IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation

BACKGROUND: Reperfusion therapy is the most effective approach to resolve coronary occlusion, but myocardial injury caused by excessive inflammation during myocardial ischemia–reperfusion will also pose a new threat to health. Our prior study revealed the expression pattern of interleukin‐38 (IL‐38)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuzhen, Xing, Junhui, Su, Xin, Li, Xiangrao, Yan, Xiaofei, Zhao, Jiangtao, Tao, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266135/
https://www.ncbi.nlm.nih.gov/pubmed/37382260
http://dx.doi.org/10.1002/iid3.898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266135/
https://www.ncbi.nlm.nih.gov/pubmed/37382260
http://dx.doi.org/10.1002/iid3.898

Ejemplares similares